Who is sponsoring NCT04579159?

NCT04579159 is sponsored by Atrial Fibrillation Network.

What drugs are being tested in NCT04579159?

Interventions in NCT04579159: Preventicus heartbeat app in combination with wearables.

What condition does NCT04579159 study?

NCT04579159 studies Atrial Arrhythmia.

Is NCT04579159 still recruiting?

NCT04579159 is currently completed. Last updated 7 July 2022.

Last reviewed 2022-07-07 · How we verify

NCT04579159: Smart in OAC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNET 9)

Completed NA Last updated 7 July 2022

What this trial tests

NA trial testing Preventicus heartbeat app in combination with wearables in Atrial Arrhythmia in 882 participants. Completed in 25 February 2022.

Timeline

26 January 2021

Primary endpoint
25 February 2022

25 February 2022

Quick facts

Lead sponsor	Atrial Fibrillation Network
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	882
Start date	26 January 2021
Primary completion	25 February 2022
Estimated completion	25 February 2022
Sites	4 locations across Spain, Germany, Poland

Drugs / interventions tested

Preventicus heartbeat app in combination with wearables

Conditions studied

Atrial Arrhythmia — all drugs for Atrial Arrhythmia →

Sponsor

Atrial Fibrillation Network

Who can join

65 and older, any sex, with Atrial Arrhythmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This feasibility study will develop and evaluate pathways to identify participants with wearable-detected absoulute Arrhythmia (AA) and to enable local study teams to contact them regarding participation in a controlled trial of oral anticoagulation in this population, which will be conducted after the feasibility study.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Smartphone and wearable detected atrial arrhythmias in Older Adults: Results of a fully digital European Case finding study.
Fabritz L, Connolly DL, Czarnecki E, Dudek D, et al · · 2022 · cited 14× · PMID 36710894 · DOI 10.1093/ehjdh/ztac067
Remote Design of a Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study: Smart in OAC - AFNET 9.
Fabritz L, Connolly D, Czarnecki E, Dudek D, et al · · 2022 · cited 4× · PMID 35387433 · DOI 10.3389/fcvm.2022.839202
Mobile health for walking on the tightrope of optimal physical activity to reduce the risk of atrial fibrillation.
Schnabel RB, Fabritz L, Kirchhof P. · · 2021 · cited 1× · PMID 34148079 · DOI 10.1093/eurheartj/ehab243

Verify or expand the search:

Other recruiting trials for Atrial Arrhythmia

Currently open trials in the same condition.

NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT07210151 — Anatomical Navigation for Guided Electrophysiology in AFL and AFib · NA · recruiting
NCT06676072 — A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF: · NA · active not recruiting
NCT06083012 — Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation · active not recruiting

Other Atrial Fibrillation Network trials

Trials by the same sponsor.

NCT07380932 — Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair · NA · not yet recruiting
NCT02933697 — Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) · Phase 3 · completed
NCT01288352 — Early Treatment of Atrial Fibrillation for Stroke Prevention Trial · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04579159 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Atrial Fibrillation Network
Last refreshed: 7 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04579159.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing